NEWSCENTRAL reports that the ongoing negotiations between the largest music label, Universal Music Group (UMG), and the investment firm Pershing Square, led by Bill Ackman, continue to draw attention. The proposed $64 billion deal promises not only to transform the company but also to significantly impact the global music market. In 2021, Pershing Square acquired a 10% stake in UMG from Vivendi, the largest shareholder of the label, for $4 billion. This marked the beginning of a series of strategic moves aimed at reshaping the company and strengthening its position in the American market.
Pershing Square’s offer to buy UMG at a 78% premium compared to the share price at the time sparked intense debate and division within the company. However, while the proposed amount appeared highly attractive, it was not solely about financial gains. Ackman made it clear from the start that his intention was to relocate UMG’s listing from Amsterdam to New York, a move he believed would provide access to a broader base of investors and significantly boost the company’s market capitalization. However, such proposals were met with resistance.
UMG, on the other hand, was not ready to accept these terms. In response to Pershing Square’s demands, the company stated that it was not obliged to move its listing to the U.S., but was open to considering the possibility if Pershing Square met certain conditions, including selling shares worth over $500 million. This legal issue became a focal point of the negotiations, and many analysts noted that it reflected not only the economic interests of the parties but also deeper questions regarding control over UMG.
Freddy Miller, a Senior Analyst at NEWSCENTRAL, emphasized that the current situation with UMG demonstrates how crucial it is to consider external risks in global markets: “In the face of instability in financial markets and the political situation continuing to affect the economy, plans to move the listing and the consequences for corporate strategy may take longer to materialize. UMG will need more time to adapt its strategy to these changes.”
In January 2025, Pershing Square reduced its stake in UMG from 10% to 7.48%, which became an important part of the broader process leading to the secondary offering of shares on the U.S. stock exchange. At the same time, UMG made its position clear by announcing it would pause its plans to list on the New York Stock Exchange, citing the unstable market conditions that had lowered its valuation.
It is also worth noting that the departure of Cyril Bolloré, one of UMG’s largest shareholders, from the board of directors in 2025 was another significant event that could have impacted the negotiations. These changes undoubtedly reflect internal instability within the company and highlight how issues of control over shares and corporate strategy can influence key decisions.
As for forecasts for UMG, experts at NEWSCENTRAL believe that in the coming years, the company will need to find new ways to increase its market capitalization. In the rapidly changing landscape of the music and digital technology market, the company will need not only to adapt its strategy but also to actively work on strengthening its position in emerging markets and expanding its influence in the digital space.
NEWSCENTRAL predicts that UMG’s future will largely depend on how the company responds to the challenges of external economic instability and what happens to its corporate structure following potential changes in its shareholder composition. It is crucial to understand that for long-term success, the company will need to balance growth in capitalization with effective management of its assets, including integrating new technologies and platforms into its business model.
Although negotiations between Pershing Square and UMG are far from over, NEWS CENTRAL asserts that this is only the beginning of global changes in the music market. UMG has a significant task ahead of it in adjusting its strategy, and ultimately, its future in the market will depend on its ability to adapt to modern challenges.